Physician profile
Robert Garner
NPI 1609525088
$2,974.77
in general payments reported to CMS, 2019-2025
9 companies · $1,012 in 2025
The $1,012 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $489 · 2024: $1,474 · 2025: $1,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,321 · Education: $653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,321.29 |
| Education | $653.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,478.09 | 2023-2025 | Blueprint Patient Specific Instrumentation, Iconix, Tornier Perform Reversed Augmented Glenoid |
| Medical Device Business Services, INC. | $653.48 | 2024-2025 | Actis |
| Zimmer Biomet Holdings, INC. | $253.90 | 2024 | Copios Bone Void Filler Paste |
| Linvatec Corporation | $174.97 | 2023 | Biobrace 23mm |
| Acumed LLC | $144.52 | 2025 | Acumed, Innate Implant |
| Bioventus LLC | $105.54 | 2025 | Exogen Ultrasound Bone Healing System |
| Titan Surgical Group, LLC | $98.15 | 2023-2025 | |
| Depuy Synthes Sales INC. | $42.02 | 2024 | |
| Davol INC. | $24.10 | 2024 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Garner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.